Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 860

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial

Bailey, Clifford J, Gross, Jorge L, Pieters, Anne, Bastien, Arnaud, List, James F·2010·The Lancet
DOI 10.1016/s0140-6736(10)60407-2
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(10)60407-2

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 19

  1. Grundy, 2008, Metabolic syndrome pandemic, Arterioscler Thromb Vasc Biol, 28, 629, 10.1161/ATVBAHA.107.151092 · DOI · Paper page
  2. Liebl, 2002, Evaluation of risk factors for development of complications in type II diabetes in Europe, Diabetologia, 45, S23, 10.1007/s00125-002-0863-0 · DOI
  3. Dodd, 2009, Treatment approach and HbA1c control among US adults with type 2 diabetes: NHANES 1999–2004, Curr Med Res Opin, 25, 1605, 10.1185/03007990902973300 · DOI
  4. Harris, 2005, Glycemic control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study), Diabetes Res Clin Pract, 70, 90, 10.1016/j.diabres.2005.03.024 · DOI
  5. Stewart, 2007, Control of type 2 diabetes mellitus among general practitioners in private practice in nine countries of Latin America, Rev Panam Salud Publica, 22, 12
  6. Krentz, 2008, New drugs for type 2 diabetes mellitus: what is their place in therapy?, Drugs, 68, 2131, 10.2165/00003495-200868150-00005 · DOI
  7. DeSouza, 2009, Therapeutic targets to reduce cardiovascular disease in type 2 diabetes, Nat Rev Drug Discov, 8, 361, 10.1038/nrd2872 · DOI
  8. Rahmoune, 2005, Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes, Diabetes, 54, 3427, 10.2337/diabetes.54.12.3427 · DOI · Paper page
  9. Ellsworth, 2008, Aglycone exploration of C-arylglucoside inhibitors of renal sodium-dependent glucose transporter SGLT2, Bioorg Med Chem Lett, 18, 4770, 10.1016/j.bmcl.2008.07.109 · DOI
  10. Komoroski, 2009, Dapagliflozin, a novel SGLT2 inhibitor, induces dose-dependent glucosuria in healthy subjects, Clin Pharmacol Ther, 85, 520, 10.1038/clpt.2008.251 · DOI · Paper page
  11. Wilding, 2009, A study of dapagliflozin in patients with type 2 diabetes receiving high doses of insulin plus insulin sensitizers: applicability of a novel insulin-independent treatment, Diabetes Care, 32, 1656, 10.2337/dc09-0517 · DOI · Paper page
  12. Buse, 2005, Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes, Clin Ther, 27, 1181, 10.1016/j.clinthera.2005.08.005 · DOI
  13. Zhang, 2008, Improving efficiency of inferences in randomized clinical trials using auxiliary covariates, Biometrics, 64, 707, 10.1111/j.1541-0420.2007.00976.x · DOI · Paper page
  14. Tsiatis, 2008, Covariate adjustment for two-sample treatment comparisons in randomized clinical trials: a principled yet flexible approach, Stat Med, 27, 4658, 10.1002/sim.3113 · DOI · Paper page
  15. de Leon, 2002, Prevalence and risk factors for vaginal candida colonization in women with type 1 and type 2 diabetes, BMC Infect Dis, 2, 1, 10.1186/1471-2334-2-1 · DOI
  16. Sobel, 1998, Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations, Am J Obstet Gynecol, 178, 203, 10.1016/S0002-9378(98)80001-X · DOI · Paper page
  17. Dupont, 1993, The place of diuretics in the treatment of hypertension: a historical review of classical experience over 30 years, Cardiovasc Drugs Ther, 7, 55, 10.1007/BF00877958 · DOI
  18. Fukui, 2008, Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus, Metabolism, 57, 625, 10.1016/j.metabol.2007.12.005 · DOI
  19. Kodama, 2009, Association between serum uric acid and development of type 2 diabetes, Diabetes Care, 32, 1737, 10.2337/dc09-0288 · DOI · Paper page

Cited by

See all 860

Metadata

Authors
Bailey, C. J., Gross, J. L., Pieters, A., Bastien, A., & List, J. F.
Venue
The Lancet
Publisher
Elsevier BV
Published
2010-06
Volume
375
Issue
9733
Pages
2223-2233
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
DOI
10.1016/s0140-6736(10)60407-2
OpenAlex
W2122077393
Cited by
860
References
9
FWCI
46.90
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • Novo Nordisk
  • GlaxoSmithKline
  • Sanofi
  • Bristol-Myers Squibb
  • AstraZeneca
  • EMD Serono

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(10)60407-2
The paper
Bailey, C. J., Gross, J. L., Pieters, A., Bastien, A., & List, J. F. (2010). Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(10)60407-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.